IBDEI0OW ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11886,1,2,0)
 ;;=2^435.2
 ;;^UTILITY(U,$J,358.3,11886,1,3,0)
 ;;=3^Subclavian Stenosis
 ;;^UTILITY(U,$J,358.3,11886,2)
 ;;=Subclavian Stenosis^115012
 ;;^UTILITY(U,$J,358.3,11887,0)
 ;;=435.9^^58^696^7
 ;;^UTILITY(U,$J,358.3,11887,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11887,1,2,0)
 ;;=2^435.9
 ;;^UTILITY(U,$J,358.3,11887,1,3,0)
 ;;=3^Trans Ischemic Attack
 ;;^UTILITY(U,$J,358.3,11887,2)
 ;;=Trans Ischemic Attack^21635
 ;;^UTILITY(U,$J,358.3,11888,0)
 ;;=435.3^^58^696^8
 ;;^UTILITY(U,$J,358.3,11888,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11888,1,2,0)
 ;;=2^435.3
 ;;^UTILITY(U,$J,358.3,11888,1,3,0)
 ;;=3^Vertebral Basilar Insuff
 ;;^UTILITY(U,$J,358.3,11888,2)
 ;;=Vertebral Basilar Insuffiency^260000
 ;;^UTILITY(U,$J,358.3,11889,0)
 ;;=438.20^^58^696^4
 ;;^UTILITY(U,$J,358.3,11889,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11889,1,2,0)
 ;;=2^438.20
 ;;^UTILITY(U,$J,358.3,11889,1,3,0)
 ;;=3^Stroke w/Hemiplegia
 ;;^UTILITY(U,$J,358.3,11889,2)
 ;;=Stroke w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,11890,0)
 ;;=438.11^^58^696^3
 ;;^UTILITY(U,$J,358.3,11890,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11890,1,2,0)
 ;;=2^438.11
 ;;^UTILITY(U,$J,358.3,11890,1,3,0)
 ;;=3^Stroke w/Aphasia
 ;;^UTILITY(U,$J,358.3,11890,2)
 ;;=Stroke w/Aphasia^317907
 ;;^UTILITY(U,$J,358.3,11891,0)
 ;;=438.6^^58^696^5.1
 ;;^UTILITY(U,$J,358.3,11891,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11891,1,2,0)
 ;;=2^438.6
 ;;^UTILITY(U,$J,358.3,11891,1,3,0)
 ;;=3^Stroke w/Sensory Loss
 ;;^UTILITY(U,$J,358.3,11891,2)
 ;;=Stroke w/Sensory Loss^328503
 ;;^UTILITY(U,$J,358.3,11892,0)
 ;;=438.7^^58^696^5.2
 ;;^UTILITY(U,$J,358.3,11892,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11892,1,2,0)
 ;;=2^438.7
 ;;^UTILITY(U,$J,358.3,11892,1,3,0)
 ;;=3^Stroke w/Vision Loss
 ;;^UTILITY(U,$J,358.3,11892,2)
 ;;=Stroke w/Vision Loss^328504
 ;;^UTILITY(U,$J,358.3,11893,0)
 ;;=438.85^^58^696^5.3
 ;;^UTILITY(U,$J,358.3,11893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11893,1,2,0)
 ;;=2^438.85
 ;;^UTILITY(U,$J,358.3,11893,1,3,0)
 ;;=3^Stroke w/Vertigo
 ;;^UTILITY(U,$J,358.3,11893,2)
 ;;=^328508
 ;;^UTILITY(U,$J,358.3,11894,0)
 ;;=438.82^^58^696^5.5
 ;;^UTILITY(U,$J,358.3,11894,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11894,1,2,0)
 ;;=2^438.82
 ;;^UTILITY(U,$J,358.3,11894,1,3,0)
 ;;=3^Stroke w/dysphagia
 ;;^UTILITY(U,$J,358.3,11894,2)
 ;;=Stroke w/dysphagia^317923
 ;;^UTILITY(U,$J,358.3,11895,0)
 ;;=438.89^^58^696^5
 ;;^UTILITY(U,$J,358.3,11895,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11895,1,2,0)
 ;;=2^438.89
 ;;^UTILITY(U,$J,358.3,11895,1,3,0)
 ;;=3^Stroke with Other Deficits
 ;;^UTILITY(U,$J,358.3,11895,2)
 ;;=^317924
 ;;^UTILITY(U,$J,358.3,11896,0)
 ;;=V12.54^^58^696^9
 ;;^UTILITY(U,$J,358.3,11896,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11896,1,2,0)
 ;;=2^V12.54
 ;;^UTILITY(U,$J,358.3,11896,1,3,0)
 ;;=3^Stroke F/U, No Residuals
 ;;^UTILITY(U,$J,358.3,11896,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,11897,0)
 ;;=345.10^^58^697^8
 ;;^UTILITY(U,$J,358.3,11897,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11897,1,2,0)
 ;;=2^345.10
 ;;^UTILITY(U,$J,358.3,11897,1,3,0)
 ;;=3^Myoclonic Seizures
 ;;^UTILITY(U,$J,358.3,11897,2)
 ;;=Myoclonic Epilepsy^268463
 ;;^UTILITY(U,$J,358.3,11898,0)
 ;;=345.11^^58^697^9
 ;;^UTILITY(U,$J,358.3,11898,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11898,1,2,0)
 ;;=2^345.11
 ;;^UTILITY(U,$J,358.3,11898,1,3,0)
 ;;=3^Myoclonic Seizures, Intractible
 ;;^UTILITY(U,$J,358.3,11898,2)
 ;;=Myoclonic, Intractable Epilepsy^268464
 ;;^UTILITY(U,$J,358.3,11899,0)
 ;;=345.50^^58^697^11
 ;;
 ;;$END ROU IBDEI0OW
